Monday, 22 June 2020

Cipla to Sell Remdesivir Under the Name Cipremi in India

Drug maker Cipla Limited on Sunday announced the launch of experimental anti-viral drug remdesivir under its brand name Cipremi in India to treat COVID-19.


from Medindia Health News https://ift.tt/2V8sgUC

No comments:

Post a Comment